13
Participants
Start Date
November 30, 2015
Primary Completion Date
September 30, 2017
Study Completion Date
September 30, 2017
[11C]UCB-J
"* Pharmaceutical form: Sterile solution for intravenous infusion~* Concentration: 20 mCi~* Route of Administration: iv"
Brivaracetam
"* Pharmaceutical form: Sterile solution for intravenous infusion~* Concentration: 10 mg/ml~* Route of Administration: iv"
Levetiracetam
"* Pharmaceutical form: Sterile solution for intravenous infusion~* Concentration: 100 mg/ml~* Route of Administration: iv"
Brivaracetam
"* Pharmaceutical form: Tablets for oral intake~* Concentration: 25 mg~* Route of Administration: oral"
Ep0074 001, New Haven
Lead Sponsor
Collaborators (1)
PRA Health Sciences
INDUSTRY
Yale University
OTHER
UCB Pharma
INDUSTRY